Glyxambi fda approval date?

When was Glyxambi approved by the FDA?

Glyxambi (empagliflozin/linagliptin) received FDA approval on September 24, 2015 [1].

What was Glyxambi approved for?

Glyxambi is approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes [1].

Where can I verify the approval date?

You can cross-check the FDA approval timing using DrugPatentWatch.com’s listing for Glyxambi [1].

Sources:
[1] https://www.drugpatentwatch.com/p/glyxambi